Josep Infesta - Valbiotis SAS Head Devel

All Insiders France . 
Stock . Valbiotis SAS . Stakeholders . Insider . Josep Infesta
ALVAL Stock  EUR 1.37  0.02  1.48%   

Insider

Josep Infesta is Head Devel of Valbiotis SAS
Phone33 5 46 28 62 58
Webhttps://www.valbiotis.com

Valbiotis SAS Management Efficiency

The company has return on total asset (ROA) of (0.2235) % which means that it has lost $0.2235 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7242) %, meaning that it generated substantial loss on money invested by shareholders. Valbiotis SAS's management efficiency ratios could be used to measure how well Valbiotis SAS manages its routine affairs as well as how well it operates its assets and liabilities.
Valbiotis SAS has accumulated 6.13 M in total debt with debt to equity ratio (D/E) of 37.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Valbiotis SAS has a current ratio of 4.27, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Valbiotis SAS until it has trouble settling it off, either with new capital or with free cash flow. So, Valbiotis SAS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Valbiotis SAS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Valbiotis to invest in growth at high rates of return. When we think about Valbiotis SAS's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Herve MBAEurobio Scientific SA
64
Jacques MartinEurobio Scientific SA
N/A
Dominique MDOSE Pharma SA
68
Silvia MDOSE Pharma SA
N/A
Thomas LamyBiosynex
N/A
Benot DinechinKalray SA
N/A
Alain MDOSE Pharma SA
N/A
Denis FortierEurobio Scientific SA
55
Louis TannyeresKalray SA
65
Thomas IffEurobio Scientific SA
N/A
Erwan MenardKalray SA
N/A
Linda MScOSE Pharma SA
56
JeanMichel GrandmouginEurobio Scientific SA
62
JeanPascal PharmDOSE Pharma SA
N/A
Brangre VasseurOSE Pharma SA
N/A
Valbiotis SA develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. Valbiotis SA was founded in 2014 and is based in Prigny, France. VALBIOTIS is traded on Paris Stock Exchange in France. Valbiotis SAS (ALVAL) is traded on Euronext Paris in France and employs 5,000 people.

Management Performance

Return On Equity-0.72
Return On Asset-0.22

Valbiotis SAS Leadership Team

Elected by the shareholders, the Valbiotis SAS's board of directors comprises two types of representatives: Valbiotis SAS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Valbiotis. The board's role is to monitor Valbiotis SAS's management team and ensure that shareholders' interests are well served. Valbiotis SAS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Valbiotis SAS's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sbastien HDR, Chairman CoFounder
Sebastien Bessy, COO Board
Pascal Sirvent, CSO Board
Fedrick Pelong, CFO Director
Philippe Sibour, Chief Consulting
Murielle Cazaubiel, CMO Board
Josep Infesta, Head Devel

Valbiotis Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Valbiotis SAS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.72
Return On Asset-0.22
Operating Margin(12.72) %
Current Valuation35.17 M
Shares Outstanding12.41 M
Shares Owned By Insiders8.39 %
Shares Owned By Institutions7.32 %
Price To Book4.38 X
Price To Sales54.06 X
Revenue2.05 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Additional Tools for Valbiotis Stock Analysis

When running Valbiotis SAS's price analysis, check to measure Valbiotis SAS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valbiotis SAS is operating at the current time. Most of Valbiotis SAS's value examination focuses on studying past and present price action to predict the probability of Valbiotis SAS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valbiotis SAS's price. Additionally, you may evaluate how the addition of Valbiotis SAS to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY